Overview

We are developing NurOwn® for a variety of neurodegenerative diseases, including our lead indication, ALS. On our Technology you can learn more about how NurOwn® works. You can learn more about our clinical program in ALS here and our preclinical programs.

ALS- Amyotrophic Lateral Sclerosis (Lou Gehrig's disease)

PRECLINICALPHASE 1PHASE 2PHASE 3

Progressive MS- Multiple Sclerosis

PRECLINICALPHASE 1PHASE 2PHASE 3

Autism

PRECLINICALPHASE 1PHASE 2PHASE 3